CARLSBAD, Calif. — Today Thermo Fisher Scientific announced that it has released a next-generation sequencing (NGS) RNA panel and workflow that enables targeted sequencing of fusion transcripts for clinical research. The new Ion Torrent AmpliSeq RNA Fusion Lung Cancer Research Panel allows simultaneous sequencing of 70 ALK, RET, ROS1, and NTRK1 fusion transcripts associated with […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced it has expanded the world’s most comprehensive next-generation sequencing (NGS) portfolio with the launch of the HiSeq X Five System and HiSeq 3000/4000 Systems. Over the last five years, the HiSeq Sequencing System family has been established as the platform of choice for high-throughput, production-scale sequencing laboratories. […]
PLEASANTON, Calif. — 10X Genomics, a provider of an innovative genomics platform, today announced that it has raised $55.5 Million in its Series B financing. Foresite Capital Management led the B round and was joined by the Series A lead, Venrock, as well as new and existing investors, including Paladin Capital Group and funds managed […]
ROCKVILLE, Md. & SAN DIEGO — Lockheed Martin (NYSE: LMT) and Illumina, Inc. (NASDAQ: ILMN) today announced a new strategic alliance to collaborate on scalable and affordable genomics solutions to provide personalized health care for national populations. Genomics is the science of studying genomes or DNA. Applied to health care, analyzing a person’s DNA sequence […]
Harderwijk, the Netherlands and Waltham, Mass –– Today GENALICE and Knome, Inc. USA jointly announced a strategic partnership to offer their products together as a turn-key solution for those using next-generation sequencing (NGS) data to interpret patients’ genomes. GENALICE MAP is an ultra-fast and highly accurate preprocessing solution for aligning and calling NGS data and […]
Boulder, Colo. and Beverly, Mass. -— ArcherDX, Inc., the NGS applications company, today announced the formation of a new, independent company, which is focused on the development of the Archer™ line of next-generation sequencing (NGS) products. ArcherDX is the result of a business unit reorganization, also announced today, in which QIAGEN N.V. (NASDAQ: QGEN, Frankfurt […]
HILDEN, Germany and BEVERLY, Massachusetts -– QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Prime Standard QIA) today announced the acquisition of the Enzyme Solutions Unit of Enzymatics, a world leader in the development, manufacturing, and OEM supply of enzymes essential to driving the adoption of Next-Generation Sequencing (NGS) and other genetic analysis technologies in life sciences research […]
EDINBURGH, Scotland & GLASGOW, Scotland — A major investment in gene sequencing technology will secure Scotland’s place as a world leader in a genomics revolution that is set to transform healthcare. The initiative will enable scientists and clinicians to access equipment that can decode the entire genetic make-up of a person for less than £750. […]
SHANGHAI — WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, announces that it has acquired NextCODE Health, a leading genomic analysis and bioinformatics company with operations in the United States and Iceland, […]
SHANGHAI — WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, announces that it has acquired NextCODE Health, a leading genomic analysis and bioinformatics company with operations in the United States and Iceland, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
